← back to search

Jack Bleesing

Istituto Giannina Gaslini · US
Area of research
Immunology · Hematology
Research interest
Research interests include Immunodeficiency and Autoimmune Disorders, Immune Cell Function and Interaction, Autoimmune and Inflammatory Disorders Research, and Hematopoietic Stem Cell Transplantation.
h-index
49
citations
9,360
works
206
NIH funding
primary concept
Medicine
email

Recent publications

Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report
Blood Advances 2025cited by 2position: middledoi
Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium
The Lancet 2023cited by 110position: middledoi
Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD
Blood 2023cited by 25position: middledoi
T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome
Blood 2021cited by 36position: middledoi
Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report
Blood 2020cited by 134position: middledoi
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function
Blood 2020cited by 101position: middledoi
Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation
Journal of Clinical Immunology 2020cited by 25position: middledoi
Successful liver transplantation in short telomere syndromes without bone marrow failure due to DKC1 mutation.
2020cited by 9position: contributordoi
Functional reprogramming of regulatory T cells in the absence of Foxp3
Nature Immunology 2019cited by 141position: middledoi
Outcomes and Treatment Strategies for Autoimmunity and Hyperinflammation in Patients with RAG Deficiency
The Journal of Allergy and Clinical Immunology In Practice 2019cited by 76position: middledoi
Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT
Journal of Clinical Immunology 2019cited by 63position: middledoi
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
Blood 2018cited by 174position: middledoi
Screening for Wiskott-Aldrich syndrome by flow cytometry
Journal of Allergy and Clinical Immunology 2018cited by 27position: middledoi
Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study
Journal of Allergy and Clinical Immunology 2017cited by 311position: middledoi
Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations
Blood 2017cited by 111position: middledoi
Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders
Journal of Allergy and Clinical Immunology 2017cited by 109position: middledoi
Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy
Science 2015cited by 677position: middledoi
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency
Journal of Clinical Investigation 2015cited by 200position: middledoi
A Modified γ-Retrovirus Vector for X-Linked Severe Combined Immunodeficiency
New England Journal of Medicine 2014cited by 410position: middledoi
Outcomes of Donor Lymphocyte Infusion for Treatment of Mixed Donor Chimerism after a Reduced-Intensity Preparative Regimen for Pediatric Patients with Nonmalignant Diseases
Biology of Blood and Marrow Transplantation 2014cited by 61position: middledoi
Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells
Proceedings of the National Academy of Sciences 2014cited by 37position: middledoi
Primary Immune Deficiency Treatment Consortium (PIDTC) report
Journal of Allergy and Clinical Immunology 2013cited by 86position: middledoi
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab
Pediatric Blood & Cancer 2012cited by 308position: middledoi
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes
Blood 2012cited by 143position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael B. Jordan · Universidad Cervantina4 papers (2012–2020)Alexandra H. Filipovich · NewYork–Presbyterian Hospital3 papers (2012–2014)Shanmuganathan Chandrakasan · Emory University3 papers (2018–2021)Sharat Chandra · Cincinnati Children's Hospital Medical Center2 papers (2020–2021)Ashish Kumar · Medical College of Wisconsin2 papers (2012–2020)Stella M. Davies · Johns Hopkins University2 papers (2014–2020)Julie Kanter · University of Alabama at Birmingham1 papers (2012–2012) · 1 papers (2018–2018)Sam Milanovich · Medical College of Wisconsin1 papers (2012–2012)Patrick McKiernan · Birmingham Women’s and Children’s NHS Foundation Trust1 papers (2020–2020) · 1 papers (2018–2018)Kathryn Quinn · Boston Medical Center1 papers (2018–2018)Jodi Skiles · Indiana University School of Medicine1 papers (2012–2012)David López · Centre de Coopération Internationale en Recherche Agronomique pour le Développement1 papers (2019–2019) · 1 papers (2018–2018)Persis Amrolia · Great Ormond Street Hospital for Children NHS Foundation Trust1 papers (2012–2012)Michael Briones · Emory University1 papers (2021–2021)Talal A. Chatila · Boston Children's Hospital1 papers (2019–2019)Marianne Ifversen · Copenhagen University Hospital1 papers (2018–2018)Avni Y. Joshi · Mayo Clinic1 papers (2018–2018)